Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Retrieved from Ohene-Agyei, P., Iqbal, A., Harding, J
Quick Answer: GLP-1 medications show clinically meaningful average weight loss in large-scale peer-reviewed trials - approximately 14.9% for semaglutide (STEP 1) and up to 20.9% for tirzepatide (SURMOUNT-1) under trial conditions
Published, peer-reviewed, placebo-controlled clinical trial data from some of the most rigorous obesity research ever conducted
Please note: While some medications available through Gala GLP-1 are FDA-approved for weight management, compounded medications are not reviewed or approved by the FDA
US$ 22.85
US$ 26.50
US$ 29.44
US$ 24.49
US$ 21.10
US$ 27.49
US$ 29.85
